Drug Pipeline

PCV20 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
2
Phase 3
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT07425392
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior…		 overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 4
1
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06049134 Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20)… Lymphoma Active, Not Recruiting
Phase 3
NCT07425392 Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior… Pneumococcal Vaccines Active, Not Recruiting
NCT07284654 Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With… Pneumococcal Vaccines Active, Not Recruiting
Phase 1
NCT07300267 A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) Pneumococcal Infection Recruiting
Sponsors Running PCV20 Trials
Vaxcyte, Inc. (2) M.D. Anderson Cancer Center (1) Merck Sharp & Dohme LLC (1)
Get alerts when PCV20 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free